Abstract

Abstract Natural killer T cells (NKT cells) have an innate immunity-like rapidity of response and the capacity to modulate effector functions of other cells. We have shown that NKT cells express the BTB-ZF transcriptional regulator PLZF. In the absence of PLZF, NKT cells developed, but lacked many innate T cell features. We have also shown that PLZF expression is not restricted to NKT cells, but is also expressed by a subset of NKT cell-like γδ T cells. Interestingly, TCR signal strength and expression of Id3 appear to control the frequency of PLZF-expressing γδ T cells. In human T cells PLZF is expressed in NKT cells, γδ T cells and, unexpectedly, in a population of CD8+ T cells. Analysis of T cells from the only known human with a biallelic loss of functional PLZF demonstrates that the development of invariant NKT cells and other PLZF-expressing T cell subsets is dependent upon expression of PLZF. The PLZF-expressing CD8+ T cells are functionally distinct from both conventional T cells and from invariant NKT cells. Furthermore, this subset of T cells is expanded in the peripheral blood of patients with metastatic melanoma; however it is greatly diminished in that of patients with autoimmune disease. Therefore, the expression of PLZF defines a new human T cell population that is differentially regulated in response to different types of immune stress. Furthermore, these data highlight important differences between the human and mouse immune system.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.